SMN1 and sarcopenia: To further understand the mechanism underlying the absence of muscle atrophy in the PND stage of SMA pathology, we analyzed the expression levels of genes involved in muscle atrophy and sarcopenia in the TA muscle at P5 by qRT-PCR.